Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Ga-68-PSMA-11 in Management of Prostate Cancer

NCT05744115 is registered in ClinicalTrials.gov with Timothy Hoffman as lead sponsor.

NCT NCT05744115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05744115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Ga-68-PSMA-11 in Management of Prostate Cancer
Lead sponsor
Timothy Hoffman
Phase
Phase 3
Overall status
Terminated
Start date
July 27, 2021
Completion date
April 14, 2022
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, prostate cancer